![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nutrition Matters, Inc., Port Townsend, WA 98368 and Medical Oncology, Mayo Clinic, Rochester, MN 55905 *
2To whom correspondence should be addressed. E-mail: markm{at}olympus.net.
A variety of health benefits, including protection against breast cancer, have been attributed to soy food consumption, primarily because of the soybean isoflavones (genistein, daidzein, glycitein). Isoflavones are considered to be possible selective estrogen receptor modulators but possess nonhormonal properties that also may contribute to their effects. Concern has arisen over a possible detrimental effect of soy in breast cancer patients because of the estrogen-like effects of isoflavones. Genistein exhibits a biphasic effect on the growth of MCF-7 cells in vitro, stimulating proliferation at low concentrations but inhibiting it at high concentrations. In ovariectomized athymic mice implanted with MCF-7 cells, both genistein and soy protein stimulate tumor growth in a dose-dependent manner. In contrast, in intact mice fed estrogen, genistein inhibits tumor growth. Although two studies in premenopausal women suggested that soy exerts estrogenic-like effects on breast tissue, recently conducted year-long studies indicated that isoflavone supplements do not affect breast tissue density in premenopausal women and may decrease density in postmenopausal women. These latter effects are opposite to those of hormone replacement therapy (HRT). Importantly, substantial data suggest that the progestogen, not the estrogen, component of HRT increases risk of developing breast cancer. Furthermore, recently conducted studies have failed to find that even HRT reduces survival in breast cancer patients. Overall, the data are not impressive that the adult consumption of soy affects the risk of developing breast cancer or that soy consumption affects the survival of breast cancer patients. Consequently, if breast cancer patients enjoy soy products, it seems reasonable for them to continue to use them.
KEY WORDS: • soy • isoflavones • genistein • breast cancer patients • survival • risk
This article has been cited by other articles:
|
|
 |
|
  Y. Zhang, Q. Li, H.-Y. Wan, W. G. Helferich, and M.-S. Wong Genistein and a Soy Extract Differentially Affect Three-Dimensional Bone Parameters and Bone-Specific Gene Expression in Ovariectomized Mice J. Nutr., December 1, 2009; 139(12): 2230 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Brown, S. M. Baidas, J. J. Hajdenberg, O. R. Kayaleh, G. K. Pennock, N. C. Shah, and J. E. Tseng Lifestyle Interventions in the Prevention and Treatment of Cancer American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 337 - 348. [Abstract] [PDF]
|
|
|
|
|
|
G. Maskarinec, M. Verheus, F. M. Steinberg, P. Amato, M. K. Cramer, R. D. Lewis, M. J. Murray, R. L. Young, and W. W. Wong Various Doses of Soy Isoflavones Do Not Modify Mammographic Density in Postmenopausal Women J. Nutr., May 1, 2009; 139(5): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rayalam, M. A. Della-Fera, J.-Y. Yang, H. J. Park, S. Ambati, and C. A. Baile Resveratrol Potentiates Genistein's Antiadipogenic and Proapoptotic Effects in 3T3-L1 Adipocytes J. Nutr., December 1, 2007; 137(12): 2668 - 2673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wu, M. C. Pike, L. D. Williams, D. Spicer, C.-C. Tseng, M. I. Churchwell, and D. R. Doerge Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer J. Clin. Oncol., July 20, 2007; 25(21): 3024 - 3030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gallo, E. Mantuano, M. Fabrizi, C. Ferlini, S. Mozzetti, I. De Stefano, and G. Scambia Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 317 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Mai, G. L. Blackburn, and J.-R. Zhou Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice Carcinogenesis, June 1, 2007; 28(6): 1217 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-Wahnefried, B. Grant, A. McTiernan, C. L. Rock, C. Thompson, T. Gansler, et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices CA Cancer J Clin, November 1, 2006; 56(6): 323 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Messina, W. McCaskill-Stevens, and J. W. Lampe Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gallo, C. Ferlini, M. Fabrizi, S. Prislei, and G. Scambia Lack of stimulatory activity of a Phytoestrogen-containing soy extract on the growth of breast cancer tumors in mice Carcinogenesis, July 1, 2006; 27(7): 1404 - 1409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Pockaj, J. G. Gallagher, C. L. Loprinzi, P. J. Stella, D. L. Barton, J. A. Sloan, B. I. Lavasseur, R. M. Rao, T. R. Fitch, K. M. Rowland, et al. Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Black Cohosh in the Management of Hot Flashes: NCCTG Trial N01CC1 J. Clin. Oncol., June 20, 2006; 24(18): 2836 - 2841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Fenton and N. G. Hord Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research Carcinogenesis, May 1, 2006; 27(5): 893 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Morris, J. Thorpe, L. Ambrosio, and M. Santin The Soybean Isoflavone Genistein Induces Differentiation of MG63 Human Osteosarcoma Osteoblasts J. Nutr., May 1, 2006; 136(5): 1166 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Trock, L. Hilakivi-Clarke, and R. Clarke Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst, April 5, 2006; 98(7): 459 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Allred, K. F. Allred, Y. H. Ju, T. S. Goeppinger, D. R. Doerge, and W. G. Helferich Soy processing influences growth of estrogen-dependent breast cancer tumors Carcinogenesis, September 1, 2004; 25(9): 1649 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Paruthiyil, H. Parmar, V. Kerekatte, G. R. Cunha, G. L. Firestone, and D. C. Leitman Estrogen Receptor {beta} Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest Cancer Res., January 1, 2004; 64(1): 423 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Norman, R. R. Butrum, E. Feldman, D. Heber, D. Nixon, M. F. Picciano, R. Rivlin, A. Simopoulos, M. J. Wargovich, E. K. Weisburger, et al. The Role of Dietary Supplements during Cancer Therapy J. Nutr., November 1, 2003; 133(11): 3794S - 3799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kurzer Phytoestrogen Supplement Use by Women J. Nutr., June 1, 2003; 133(6): 1983S - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cabot Phytoestrogens J. Am. Acad. Ortho. Surg., May 1, 2003; 11(3): 153 - 156. [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Weiger, M. Smith, H. Boon, M. A. Richardson, T. J. Kaptchuk, and D. M. Eisenberg Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer Ann Intern Med, December 3, 2002; 137(11): 889 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maggiolini, A. Vivacqua, A. Carpino, D. Bonofiglio, G. Fasanella, M. Salerno, D. Picard, and S. Ando The Mutant Androgen Receptor T877A Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Genistein and Quercetin on Human LNCaP Prostate Cancer Cells Mol. Pharmacol., November 1, 2002; 62(5): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Brownson, N. G. Azios, B. K. Fuqua, S. F. Dharmawardhane, and T. J. Mabry Flavonoid Effects Relevant to Cancer J. Nutr., November 1, 2002; 132(11): 3482S - 3489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Shanafelt, D. L. Barton, A. A. Adjei, and C. L. Loprinzi Pathophysiology and Treatment of Hot Flashes Mayo Clin. Proc., November 1, 2002; 77(11): 1207 - 1218. [Abstract] [PDF]
|
|
|
|
|
|
Z. Jin and R. S. MacDonald Soy Isoflavones Increase Latency of Spontaneous Mammary Tumors in Mice J. Nutr., October 1, 2002; 132(10): 3186 - 3190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Wu, P. Wan, J. Hankin, C.-C. Tseng, M. C. Yu, and M. C. Pike Adolescent and adult soy intake and risk of breast cancer in Asian-Americans Carcinogenesis, September 1, 2002; 23(9): 1491 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Lemos, C. L. Van Patten, K. A. Gelmon, and I. A. Olivotto Safety Issues of Soy Phytoestrogens in Breast Cancer Patients J. Clin. Oncol., July 1, 2002; 20(13): 3040 - 3042. [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Birdsall, S. Rey, J. Martin, and M. Rogers Naturopathic Medicine Analysis Integr Cancer Ther, June 1, 2002; 1(2): 189 - 192. [PDF]
|
|
